Data as of Mar 10
| +0.05 / +0.16%|
The 5 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 33.00, with a high estimate of 55.00 and a low estimate of 26.00. The median estimate represents a +6.28% increase from the last price of 31.05.
The current consensus among 5 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.